SCHEMBL9683520

SCHEMBL9683520

Nc1cc(Cl)ccc1NCc1ccc(Cl)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM5 Q9NZQ8 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ADRA2B P18089 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BCDIN3D Q7Z5W3 1/20 0.40
CYP3A4 P08684 2/20 0.39
PLA2G1B P04054 1/20 0.39
CYP2D6 P10635 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
VNN1 O95497 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683479 0.90 AKR1B1 (0.43) TRPM5MEN1KMT2AADRA2BCYP1A2
SCHEMBL6744214 0.77 ALDH1A1 (0.42) ALDH1A1HPGDCYP3A4CA1CA2
SCHEMBL11569274 0.77 ALDH1A1 (0.49) MEN1KMT2AALDH1A1HPGDL3MBTL1
SCHEMBL9683129 0.76 MAPT (0.47) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL15076829 0.75 CXCR3 (0.43) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL9683485 0.75 MAPT (0.60) MEN1KMT2ACYP1A2CYP2C9CYP2C19
SCHEMBL9681422 0.74 HDAC1 (0.40) ADRA2BALDH1A1AKR1B1HDAC1
SCHEMBL11274390 0.73 PKM (0.52) ALDH1A1HPGDSMN1; SMN2
SCHEMBL3787955 0.72 ALDH1A1 (0.54) KMT2AALDH1A1HPGDCYP3A4TSHR
SCHEMBL13881914 0.72 SLC6A4 (0.58) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5124336-A Cardiovascular disorders LABORATOIRES UPSA (FR) 1992-06-23 US disclosed